Cellular Dynamics International Inc.

Cellular Dynamics International Inc. is using induced pluripotent stem (iPS) cells, derived from adult cells, as drug discovery and development tools. The company is initially pursuing the cardiotoxicity market with iCell cardiomyocytes, which closely resemble in vivo cardiomyocytes, even beating in unison in a cell culture dish. When exposed to drugs or other external agents, the cells produce electrophysiological and biochemical responses typical of in vivo cardiomyocytes.

525 Science Drive

Madison, WI 53711

More from Cell Therapies

More from Advanced Therapies

Positive Fabry Data Should Smooth Way For Sangamo’s Partnering Efforts

 

The biotech announced results from the pivotal trial of isaralgagene civoparvovec and plans to file for approval in 2026 as it looks for a commercialization partner.

Saudi Arabia Plans Advanced Manufacturing Campus Under Biotech Drive

 
• By 

A partnership with Germfree Laboratories will bring a new facility to boost Saudi Arabia’s biotech sector as the world’s largest oil exporter tries to establish itself as a global biotech hub by 2040.

Vertex Heralds ‘Unprecedented’ Zimislecel Type 1 Diabetes Data

 
• By 

The off-the-shelf stem cell therapy shows sustained glycemic control and a high rate of insulin independence.